Background risk should be taken into account when reporting vaccine effectiveness
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu dopisy, komentáře
PubMed
35043536
DOI
10.1111/ajt.16961
PII: S1600-6135(22)08284-3
Knihovny.cz E-zdroje
- MeSH
- systémy pro sběr zpráv o nežádoucích účincích léků * MeSH
- účinnost vakcíny * MeSH
- vakcinace MeSH
- Publikační typ
- dopisy MeSH
- komentáře MeSH
Zobrazit více v PubMed
Reischig T, Kacer M, Vlas T, et al. Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic. Am J Transplant. 2021. doi:10.1111/ajt.16902
Orenstein WA, Bernier RH, Dondero TJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ. 1985;63(6):1055-1068.
CMMID COVID-19 Working Group, Davies NG, Jarvis CI, et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature. 2021;593(7858):270-274. doi:10.1038/s41586-021-03426-1
Angel Y, Spitzer A, Henig O, et al. Association between vaccination with BNT162b2 and incidence of symptomatic and asymptomatic SARS-CoV-2 infections among health care workers. JAMA. 2021;325(24):2457. doi:10.1001/jama.2021.7152
Komenda M, Bulhart V, Karolyi M, et al. Complex reporting of the COVID-19 epidemic in the Czech Republic: use of an interactive web-based app in practice. J Med Internet Res. 2020;22(5):e19367. doi:10.2196/19367
Weinberg GA, Szilagyi PG. Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. J Inf Dis. 2010;201(11):1607-1610. doi:10.1086/652404
Qin CX, Moore LW, Anjan S, et al. Risk of breakthrough SARS-CoV-2 infections in adult transplant recipients. Transplantation. 2021;105(11):e265-e266. doi:10.1097/TP.0000000000003907
Aslam S, Adler E, Mekeel K, Little SJ. Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients. Transpl Infect Dis. 2021;23(5): doi:10.1111/tid.13705